Stay updated on ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.

Latest updates to the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe site revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check30 days agoChange DetectedA sitewide notice says NIH agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check44 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.7.0 was added as the latest revision to the record history, replacing the previous Revision: v3.6.6. This indicates an updated version of the page, without changes to the underlying study data or descriptions.SummaryDifference0.1%

- Check79 days agoChange DetectedAn additional revision entry, v3.6.6, has been added to the study record history, indicating an update to the record. The prior revision listed was v3.6.5.SummaryDifference0.1%

Stay in the know with updates to ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.